If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The calculation of the percentage of the class beneficially owned by the reporting person is based on 115,038,025 shares of common stock outstanding as of July 22, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q, filed with the SEC on July 29, 2026.


SCHEDULE 13D


 
Alexander Otto
 
Signature:/s/ Frederic Arndts
Name/Title:By: Frederic Arndts, managing director of KG CURA Vermogensverwaltung G.m.b.H. & Co Vice President and Senior Counsel, Capital Research and Management
Date:08/14/2026